ACE2 converts angiotensin (Ang) II into the vasodilator and antitrophic heptapeptide, Ang‐(1–7), which exerts protective effects on the lung and cardiac vasculature making it potentially beneficial in COVID‐19 patients.5, 12, 13. The gene discussed is ACE2; the disease is COVID-19.